期刊文献+
共找到739篇文章
< 1 2 37 >
每页显示 20 50 100
1-Heptanesulfonic acid sodium salt:One pot efficient synthesis of 2-aryl-1-arylmethyl-1H-1,3-benzo[d]imidazoles 被引量:1
1
作者 Ganesh R.Jadhav Mohammad U.Shaikh +1 位作者 Rajesh P Kale Charansingh H.Gill 《Chinese Chemical Letters》 SCIE CAS CSCD 2009年第5期535-538,共4页
Synthesis of 2-aryl-1-arylmethyl-1H-1,3-benzo[d]imidazoles by the reaction of o-phenylenediamine with substituted aromatic aldehydes in the presence of 1-heptanesulfonic acid sodium salt (10 mol%) at room temperatur... Synthesis of 2-aryl-1-arylmethyl-1H-1,3-benzo[d]imidazoles by the reaction of o-phenylenediamine with substituted aromatic aldehydes in the presence of 1-heptanesulfonic acid sodium salt (10 mol%) at room temperature. The reactions were performed in acetonitrile:water (8:2). The method was proved to be eco-friendly, convenient and the products were isolated with good yields (82- 90%). 展开更多
关键词 1-Heptanesulfonic acid sodium salt Water Aryl aldehyde BENZIMIDAZOLE
下载PDF
依达拉奉右莰醇联合丁苯酞氯化钠注射液对急性脑梗死患者血清单核细胞趋化蛋白-1、内皮素-1表达的影响 被引量:3
2
作者 杨华英 崔娅晖 +1 位作者 郑连红 王琮民 《中国药业》 CAS 2024年第9期135-138,共4页
目的探讨依达拉奉右莰醇联合丁苯酞氯化钠注射液对急性脑梗死患者血清单核细胞趋化蛋白-1(MCP-1)、内皮素-1(ET-1)表达及动脉粥样硬化斑块的影响。方法选取河北省邯郸市中医院2020年12月至2022年8月收治的急性脑梗死患者140例,按随机数... 目的探讨依达拉奉右莰醇联合丁苯酞氯化钠注射液对急性脑梗死患者血清单核细胞趋化蛋白-1(MCP-1)、内皮素-1(ET-1)表达及动脉粥样硬化斑块的影响。方法选取河北省邯郸市中医院2020年12月至2022年8月收治的急性脑梗死患者140例,按随机数字表法分为联合组和对照组,各70例。两组患者均予丁苯酞氯化钠注射液,联合组患者加用依达拉奉右莰醇注射液,均治疗14 d。结果联合组总有效率为91.43%,显著高于对照组的68.57%(P<0.05)。治疗后,两组患者的颈动脉内中膜厚度、斑块面积、美国国立卫生研究院卒中量表(NIHSS)评分、改良Rankin量表(MRS)评分及血清MCP-1、ET-1、丙二醛、超氧化物歧化酶水平均显著降低(P<0.05),且联合组均显著低于对照组(P<0.05);联合组和对照组患者治疗期间不良反应发生率相当(12.86%比14.29%,P>0.05)。结论依达拉奉右莰醇联合丁苯酞氯化钠注射液治疗急性脑梗死的临床疗效良好,可有效改善患者的神经功能缺损情况、颈动脉粥样硬化斑块稳定性及内皮功能,降低氧化应激水平,提高生活质量,且安全性良好。 展开更多
关键词 急性脑梗死 丁苯酞氯化钠注射液 依达拉奉右莰醇 单核细胞趋化蛋白-1 内皮素-1 氧化应激 动脉粥样硬化斑块
下载PDF
The Effect of Sodium Butyrate in Combination with ATRA on the Proliferation/Differentiation of SKM-1 被引量:1
3
作者 黄梅 刘文励 +4 位作者 李春蕊 邓金牛 周剑锋 张东华 孙汉英 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2004年第4期334-337,共4页
To explore the molecular mechanisms of sodium butyrate working on SKM-1 cell proliferation/differentiation and to study its synergistic effect with all-trans retinoic acid (ATRA), SKM-1 cells were grown in the absence... To explore the molecular mechanisms of sodium butyrate working on SKM-1 cell proliferation/differentiation and to study its synergistic effect with all-trans retinoic acid (ATRA), SKM-1 cells were grown in the absence or presence of sodium butyrate and/or ATRA. The percentage of viable cells was determined by trypan blue exclusion. Differentiation was determined by nitroblue tetrazolium (NBT) reduction and cell surface adhesion molecules was analyzed by FACS. Cell cycle distribution was examined after DNA staining by propidium iodide. D-type cyclins, cdks and P21 mRNA were studied by reverse transcription-polymerase chain reaction. Our results showed that sodiun butyrate and/or ATRA blocked cells mainly in the G 0/G 1 phase of the cell cycle. ATRA inhibited the mRNA expression of CDK6, CDK4, cyclinD3 and cyclinD1. Sodium butyrate inhibited the mRNA expression of CDK2, cyclinD2 and cyclinD1. ATRA and sodium butyrate inhibited the mRNA expression of CDK6, CDK4, CDK2, cyclinD1, cyclinD2 and cyclinD3. Both ATRA and/or sodium butyrate stimulated p21 expression at the mRNA levels. Our results suggest that the effect of sodium butyrate on cell proliferation/differentiation might be linked to its ability to induce expression of p21 mRNA and inhibit the cyclin-cdk complexes. Our observations support the notion that the sodium butyrate works synergistically with ATRA. 展开更多
关键词 sodium butyrate ATRA SKM-1 cell cycle
下载PDF
Expression and Purification of Hydrophilic Domains of Bovine Anion Exchanger,Member 1 and Electrogenic Sodium Bicarbonate Cotransporter 1
4
作者 TIAN Wei YU Duo-wei 《Animal Husbandry and Feed Science》 CAS 2009年第8期10-13,共4页
[ Objective] To express and purify the intracellular hydrophilic domains of bovine membrane carrier proteins:anion exchanger, member 1 (AE1) and electregenic sodium bicarbonate cotransporter 1 (NBCel), which were... [ Objective] To express and purify the intracellular hydrophilic domains of bovine membrane carrier proteins:anion exchanger, member 1 (AE1) and electregenic sodium bicarbonate cotransporter 1 (NBCel), which were associated with bicarbonate ion transport. [ Method] The hydrophilic domains of bovine AE1 and NBCel were amplified by PCR and inserted into the prokaryotic expression vector pET-28a, respectively. The recombinant plasmids were transformed into the expression strain E. coli BL21 (DE3) and then induced by IPTG. The expressed proteins were purified by nickel ion affinity chromatography and analyzed by 15% SDS-PAGE. [Result] The hydrophilic domains of bovine AE1 and NBCel were amplified respectively by PCR and expressed by prokaryotic expression system with the induction of IPTG. They were mainly expressed in the cyto- plasm of E. coli and high-purity was achieved by nickel ion affinity chromatography. [Condusion] The expression of the hydrophilic domains of bovine AE1 and NBCel provides a major exit route for preparation of antibodies and the regulatory mechanisms of carrier proteins. 展开更多
关键词 Anion exchanger Member 1 Electregenic sodium bicarbonate cotransporter 1 Cloning Expression Purification
下载PDF
A novel mutation in the sodium channel α1 subunit gene in a child with Dravet syndrome in Turkey
5
作者 Mutluay Arslan Ulu Yis +1 位作者 Hande aglayan Ridvan Akin 《Neural Regeneration Research》 SCIE CAS CSCD 2013年第10期955-958,共4页
Dravet syndrome is a rare epileptic encephalopathy characterized by frequent seizures beginning in the first year of life and behavioral disorders. Mutations in the sodium channel α1 subunit gene are the main cause o... Dravet syndrome is a rare epileptic encephalopathy characterized by frequent seizures beginning in the first year of life and behavioral disorders. Mutations in the sodium channel α1 subunit gene are the main cause of this disease. We report two patients with refractory seizures and psychomotor retardation in whom the final diagnosis was Dravet syndrome with confirmed mutations in the sodium channel α1 subunit gene. The mutation identified in the second patient was a novel frame shift mutation, which resulted from the deletion of five nucleotides in exon 24. 展开更多
关键词 neural regeneration clinical practice Dravet syndrome sodium channel (]1 subunit gene MUTATION CHILD TURKISH EPILEPSY refractory seizures NEUROREGENERATION
下载PDF
MODULATION OF MDR-1 GENE IN HUMAN BREAST CANCER CELLS BY SODIUM BUTYRATE AND DMSO
6
作者 张荣河 何三光 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2001年第1期27-30,共4页
Objective: To analyze the regulation effect of MDR-1 gene in human breast cancer cell by the differentiating agents, sodium butyrate and dimethyl sulfoxide. Methods: 1. A sensitive assay, RT-PCR, was used to measure t... Objective: To analyze the regulation effect of MDR-1 gene in human breast cancer cell by the differentiating agents, sodium butyrate and dimethyl sulfoxide. Methods: 1. A sensitive assay, RT-PCR, was used to measure the mRNA level before and after the treatment of sodium butyrate, DMSO, using β-actin as control; 2. Evaluated the effect of sodium butyrate, DMSO on MDR-1 gene expression of human breast cancer at the protein level by immunoflow cytometry; 3. P-glycoprotein function was examined after accumulation of the fluorescent drug, Phodamine-123, by flow cytometry; 4. Chemosensitivity to doxorubicin was analyzed using the MTT assay. Results: Sodium butyrate and DMSO were found to increase the MDR characteristics on MDR-1 gene, MDR-1 expression levels, P-glycoprotein function and chemosensitivity to doxorubicin. Conclusion: sodium butyrate, DMSO can modulate the MDR-1 gene at gene level, protein level, protein function level and cell level. 展开更多
关键词 MDR-1 sodium butyrate DMSO Breast cancer
下载PDF
Room Temperature Phosphorescence of 1-Bromo-4-(bromoacetyl) naphthalene Induced by Sodium Deoxycholate
7
作者 YuWANG WeiJunJIN JianBingCHAO LiPingQIN 《Chinese Chemical Letters》 SCIE CAS CSCD 2004年第3期339-342,共4页
Sodium deoxycholate (NaDOC) could induce 1-bromo-4-(bromoacetyl) naphthalene (BBAN) to emit strong room temperature phosphorescence (RTP). Measurements of phosphore- scence spectra, peak intensity and polarization we... Sodium deoxycholate (NaDOC) could induce 1-bromo-4-(bromoacetyl) naphthalene (BBAN) to emit strong room temperature phosphorescence (RTP). Measurements of phosphore- scence spectra, peak intensity and polarization were used to investigate the solubilization of BBAN as a function of NaDOC concentration. 展开更多
关键词 sodium deoxycholate 1-bromo-4-(bromoacetyl) naphthalene room temperature phos- phorescence.
下载PDF
禽白血病病毒J亚群感染鸡组织中细胞受体chNHE 1的表达分析
8
作者 张莉 于蒙蒙 +7 位作者 王颖 王素艳 许壮壮 刘鹏 陈运通 祁小乐 李留安 高玉龙 《畜牧兽医学报》 CAS CSCD 北大核心 2024年第8期3631-3639,共9页
旨在研究鸡钠氢交换蛋白1(chicken sodium hydrogen exchanger isoform 1,chNHE1)在不同类型鸡组织内的表达情况,J亚群禽白血病病毒(subgroup J avian leukosis virus, ALV-J)的组织嗜性及ALV-J感染后组织chNHE1的mRNA变化情况。本研究... 旨在研究鸡钠氢交换蛋白1(chicken sodium hydrogen exchanger isoform 1,chNHE1)在不同类型鸡组织内的表达情况,J亚群禽白血病病毒(subgroup J avian leukosis virus, ALV-J)的组织嗜性及ALV-J感染后组织chNHE1的mRNA变化情况。本研究利用qPCR技术,检测了商品肉鸡、商品蛋鸡和SPF鸡脏器内的chNHE1转录量,ALV-J感染鸡后各组织的病毒载量及组织chNHE1的转录量的变化。结果显示,chNHE1在3种类型鸡的心、肝、脾、肺、肾、盲肠扁桃体、胸腺和法氏囊中均能检测到,但转录量高低存在较大差异,其中,免疫器官内的chNHE1转录量相对较高;SPF鸡接种ALV-J后,心、脾、肾和盲肠扁桃体中的病毒载量相对较高,而肝、肺、胸腺和法氏囊中的病毒载量相对较低;ALV-J感染后,脾、肾和盲肠扁桃体中的chNHE1转录量明显上调,但心中的转录量与空白对照相比无明显变化。本研究分析了3种类型鸡chNHE1的组织转录特点及ALV-J感染对组织内chNHE1转录的影响,该研究结果为探究受体chNHE1的转录与ALV-J的组织嗜性的关系提供重要的理论依据。 展开更多
关键词 J亚群禽白血病病毒 鸡钠氢交换蛋白1 组织表达 转录量变化
下载PDF
Analgesic effect of intrathecal bumetanide is accompanied by changes in spinal sodium-potassium-chloride co-transporter 1 and potassium-chloride co-transporter 2 expression in a rat model of incisional pain 被引量:2
9
作者 Yanbing He Shiyuan Xu +1 位作者 Junjie Huang Qingjuan Gong 《Neural Regeneration Research》 SCIE CAS CSCD 2014年第10期1055-1062,共8页
Accumulating evidence has demonstrated that the sodium-potassium-chloride co-transporter 1 and potassium-chloride co-transporter 2 have a role in the modulation of pain transmission at the spinal level through chlorid... Accumulating evidence has demonstrated that the sodium-potassium-chloride co-transporter 1 and potassium-chloride co-transporter 2 have a role in the modulation of pain transmission at the spinal level through chloride regulation in the pain pathway and by effecting neuronal excitability and pain sensitization. The present study aimed to investigate the analgesic effect of the speciifc sodium-potassium-chloride co-transporter 1 inhibitor bumetanide, and the change in spinal sodium-potassium-chloride co-transporter 1 and potassium-chloride co-transporter 2 expression in a rat model of incisional pain. Results showed that intrathecal bumetanide could decrease cumulative pain scores, and could increase thermal and mechanical pain thresholds in a rat model of incisional pain. Sodium-potassium-chloride co-transporter 1 expression in-creased in neurons from dorsal root ganglion and the deep laminae of the ipsilateral dorsal horn following incision. By contrast, potassium-chloride co-transporter 2 expression decreased in neurons of the deep laminae from the ipsilateral dorsal horn. These ifndings suggest that spinal sodium-potassium-chloride co-transporter 1 expression was up-regulated and spinal potassi-um-chloride co-transporter 2 expression was down-regulated following incision. Intrathecal bumetanide has analgesic effects on incisional pain through inhibition of sodium-potassi-um-chloride co-transporter 1. 展开更多
关键词 nerve regeneration sodium-potassium-chloride co-transporter 1 potassium-chloride co-transporter 2 BUMETANIDE spinal cord dorsal root ganglion incision model postoperative pain neural regeneration
下载PDF
肝癌患者血浆ctDNA SCNM1甲基化水平检测及与临床预后评估价值研究
10
作者 王娟 杨柳 刘家云 《现代检验医学杂志》 CAS 2024年第6期18-22,36,共6页
目的 探讨肝细胞癌(hepatocellular carcinoma,HCC)患者血浆游离肿瘤DNA (circulating tumour DNA,ctDNA)中钠离子通道调节蛋白1(sodium channel modifier 1,SCNM1)甲基化水平与患者预后的关系。方法 选择2018年6月~2020年12月空军军医... 目的 探讨肝细胞癌(hepatocellular carcinoma,HCC)患者血浆游离肿瘤DNA (circulating tumour DNA,ctDNA)中钠离子通道调节蛋白1(sodium channel modifier 1,SCNM1)甲基化水平与患者预后的关系。方法 选择2018年6月~2020年12月空军军医大学第一附属医院收治的67例肝细胞癌患者作为HCC组,同期健康人群50例作为对照组,收集对比患者临床资料。微滴式数字PCR(droplet digital PCR,ddPCR)检测血浆ctDNA SCNM1甲基化水平。比较不同组别间血清甲胎蛋白(alpha fetoprotein,AFP)、丙氨酸氨基转移酶(cereal third transaminase,ALT)、天冬氨酸氨基转移酶(aspartate transaminase,AST)、ctDNA水平和SCNM1甲基化比率的差异;比较不同SCNM1甲基化水平和不同预后患者临床病理特征差异,多因素COX回归分析肝细胞癌患者的预后影响因素;受试者工作特征(ROC)曲线分析SCNM1甲基化水平对预后判断的灵敏度和特异度。结果 HCC组血浆AFP水平[351.00(14.90,1 210.00)ng/ml]、ctDNA水平[57.65(15.79,171.90)ng/ml]、SCNM1甲基化水平[13.23%(4.36%,26.61%)]均高于对照组[2.90(2.20,5.10)ng/ml,15.75(12.85,21.07)ng/ml,4.69%(3.30%,6.68%)],差异具有统计学意义(Z=-7.18,-5.00,-4.77,均P <0.05);肿瘤病灶直径> 2cm,HCC远处转移患者的SCNM1甲基化呈现高水平(χ^(2)=5.01,38.85,均P <0.05);SCNM1甲基化检测高水平组患者中位生存期短于低水平组(13.31月vs. 24.44月),差异具有统计学意义(Log rankχ^(2)=4.141,P=0.04),SCNM1甲基化高水平是患者生存的独立影响因素(95%CI:2.449~62.716,P=0.002);SCNM1甲基化预测肝细胞癌患者病情进展的AUC(95%CI)为0.716(0.583~0.848),其敏感度和特异度分别为63.0%和81.1%。SCNM1甲基化、ctDNA联合AFP对肝细胞癌进展预测的AUC(95%CI)为0.747(0.618~0.875),敏感度和特异度分别为55.6%,91.9%。结论 SCNM1甲基化高水平提示HCC患者预后不良,是患者生存的独立影响因素,SCNM1甲基化、ctDNA,联合AFP检测可作为预后判断标志物。 展开更多
关键词 循环肿瘤DNA 钠离子通道调节蛋白1 肝细胞癌 甲基化
下载PDF
Resuscitation from Prolonged Ventricular Fibrillation by Epinephrine Combined with Sodium-Hydrogen Exchanger Isoform-1 Inhibitor Cariporide
11
作者 易忠 《South China Journal of Cardiology》 CAS 2002年第1期30-34,共5页
Objective To test the resuscitative effects from prolonged ventricular fibrillation by epinephrine combined with sodium hydrogen exchanger isoform 1 inhibitor Cariporide. Methods 16 rats were received a 3 mg/kg bolu... Objective To test the resuscitative effects from prolonged ventricular fibrillation by epinephrine combined with sodium hydrogen exchanger isoform 1 inhibitor Cariporide. Methods 16 rats were received a 3 mg/kg bolus of Cariporide or the same volume of 0.9%NaCl solution (control) 15 seconds before completion 12 minutes untreated VF. Chest compression (CC) was started for a total of 8 minutes. Adjusted the depth of compressor so that the aortic diastolic pressure to 25~28 mmHg during the 2nd minute of CC. Fix the depth of the piston and this depth was used throughout the remaining 6 minutes of CC. 10 seconds before starting the 3rd minute of chest compression, injected epinephrine (30 μg/kg). Recorded the time at which restoration of spontaneous circulation (ROSC) occurred in Cariporide treated rats. Electrical defibrillation was timed in control group to match the time of spontaneous defibrillation in Cariporide treated rats. To the rats, which cant be defibrillated spontaneously, received chest compression and rescues electrical shocks. Results compared with control group, with the same CC depth, Cariporide treated rats received the higher and longer lasting coronary perfusion pressure (P< 0.05), higher resuscitative rate (P< 0.05), less post resuscitative ventricular ectopic activities (P< 0.001), better hemodynamic effects and longer survival time (P< 0.05). Conclusion Epinephrine combined with sodium hydrogen exchanger isoform 1 inhibitor Cariporide may represent a novel and remarkably effective intervention for resuscitation from prolonged VF. 展开更多
关键词 Cardiopulmonary resuscitation Prolonged ventricular fibrillation Epinephrine sodium hydrogen exchanger isoform 1 inhibitor Coronary perfusion pressure
下载PDF
Crystal and Molecular Structure, and Spectral Characteristics of Sodium 3,5-Bis(Hydroxyimino)-1-Methyl-2,4,6-Trioxocyclohexanide
12
作者 Olga Kovalchukova Nguyen Dinh Do +6 位作者 Adam Stash Vitaly Bel’sky Paul Strashnov Andrew Alafinov Oleg Volyansky Svetlana Strashnova Konstantin Kobrakov 《Crystal Structure Theory and Applications》 2012年第3期46-51,共6页
Sodium 3,5-bis(hydroxyimino)-1-methyl-2,4,6-trioxocyclohexanide C7H5N2NaO5 (I) has been isolated as the only product of the reaction of nitrosation of methylphloroglucinol. The structure of the titled compound has bee... Sodium 3,5-bis(hydroxyimino)-1-methyl-2,4,6-trioxocyclohexanide C7H5N2NaO5 (I) has been isolated as the only product of the reaction of nitrosation of methylphloroglucinol. The structure of the titled compound has been determined from single crystal X-ray diffraction data. The hydrated C7H5N2NaO52.5H2O crystallizes in the monoclinic space group C2/c, with a(?) 16.408(3);b(?) 12.446(3);c(?) 13.716(3);(o) 126.34(3). The planar organic anion exists in a triketo-dihydroxyimino form with the C–O and C–N distances from 1.220(2) to 1.271(2)?? and from 1.292(2) to 1.293?? respectively. In the IR spectrum of I, the sharp absorption band occurred at 1681 cm-1 due to C=O stretching indicating the strong H-interactions. The correlations of theoretical (DFT-B3LYP/aug-cc-pVDZ) and experimental UV-vis absorption spectra in neutral and alkaline ethanolic solutions showed the existence of hydroxyimino-nitroso tautomerism while ionization of I. 展开更多
关键词 sodium 3 5-Bis(Hydroxyimino)-1-Methyl-2 4 6-Trioxocyclohexanide CRYSTAL Structure IR SPECTRA Electronic Absorption SPECTRA Quantum Chemical Modeling
下载PDF
无机钠源对O_(3)-NaNi_(1/3)Fe_(1/3)Mn_(1/3)O_(2)性能的影响
13
作者 谢伟超 朱贤徐 +2 位作者 吴志康 唐朝辉 李加兴 《电池》 CAS 北大核心 2024年第3期383-389,共7页
O_(3)型层状氧化物正极材料NaNi_(1/3)Fe_(1/3)Mn_(1/3)O_(2)具有高比容量、低成本和较高循环寿命等特点。为探究钠源对该材料电化学性能的影响,以Na2CO_(3)、NaOH、NaHCO_(3)和Na2SO4等无机钠盐为钠源,采用高温固相反应制得一系列的O_(... O_(3)型层状氧化物正极材料NaNi_(1/3)Fe_(1/3)Mn_(1/3)O_(2)具有高比容量、低成本和较高循环寿命等特点。为探究钠源对该材料电化学性能的影响,以Na2CO_(3)、NaOH、NaHCO_(3)和Na2SO4等无机钠盐为钠源,采用高温固相反应制得一系列的O_(3)-NaNi_(1/3)Fe_(1/3)Mn_(1/3)O_(2)材料,通过SEM、X射线光电子能谱(XPS)、XRD、比表面积分析等检测手段分析钠源对O_(3)-NaNi_(1/3)Fe_(1/3)Mn_(1/3)O_(2)材料形貌、结构和电化学性能的影响。不同钠源制备的材料均为一次颗粒聚集而成的多晶结构,平均二次粒径D50均小于5μm;以Na2CO_(3)作为钠源得到的O_(3)-NaNi_(1/3)Fe_(1/3)Mn_(1/3)O_(2)材料的电化学性能最佳,组装的扣式电池以0.1 C在2.0~4.0 V充放电,首次放电比容量达141.7 mAh/g、库仑效率为95.4%,以1.0 C循环100次,放电比容量从137.2 mAh/g降低至114.3 mAh/g,容量保持率为83.3%。 展开更多
关键词 钠离子电池 无机钠源 NaNi_(1/3)Fe_(1/3)Mn_(1/3)O_(2) 正极材料 电化学性能
下载PDF
米扎格列净通过抑制钠-葡萄糖共转运体1的功能抑制常染色体显性多囊肾细胞增殖和纤维化
14
作者 刘雯瑜 吴双成 +4 位作者 张天琛 付莉莉 解良瑜 胡菀芊 郁胜强 《海军军医大学学报》 CAS CSCD 北大核心 2024年第11期1343-1351,共9页
目的探究钠-葡萄糖共转运体1(SGLT1)抑制剂米扎格列净(MIZA)在常染色体显性多囊肾病(ADPKD)中的作用。方法用蛋白质印迹法、qPCR、免疫荧光染色测定PKD1^(-/-)小鼠和PKD1^(+/+)小鼠肾脏组织、人肾癌旁组织和人ADPKD组织中SGLT1的表达和... 目的探究钠-葡萄糖共转运体1(SGLT1)抑制剂米扎格列净(MIZA)在常染色体显性多囊肾病(ADPKD)中的作用。方法用蛋白质印迹法、qPCR、免疫荧光染色测定PKD1^(-/-)小鼠和PKD1^(+/+)小鼠肾脏组织、人肾癌旁组织和人ADPKD组织中SGLT1的表达和分布。用MIZA处理囊肿衬里上皮细胞OX161和肾小管上皮细胞UCL93,37℃孵育24、48和72 h后通过MTT实验和集落形成实验观察细胞增殖情况。以100μmol/L MIZA处理OX161细胞48 h后,通过qPCR测定细胞中α1-Ⅰ型胶原蛋白、α1-Ⅲ型胶原蛋白和纤连蛋白1的mRNA表达量。用犬肾细胞MDCK 3D囊肿形成实验验证MIZA对囊肿形成的作用。通过mRNA-seq数据分析筛选UCL93细胞和OX161细胞、OX161细胞和100μmol/L MIZA处理48 h后的OX161细胞的差异表达基因,利用京都基因与基因组百科全书(KEGG)数据库进行通路富集分析。结果SGLT1在ADPKD患者和PKD1^(-/-)小鼠多囊肾组织中的表达水平较正常肾脏组织升高(P<0.05,P<0.01),免疫荧光染色发现SGLT1主要表达在囊肿衬里上皮细胞。在体外实验中,MIZA呈浓度和时间依赖性地抑制多囊肾细胞的增殖和纤维化,3D形成实验表明MIZA抑制了囊肿的形成。mRNA-seq数据分析和KEGG富集分析结果显示,OX161细胞和100μmol/L MIZA处理48 h的OX161细胞的差异表达基因主要富集在PI3K-Akt、MAPK等信号通路,与OX161细胞和UCL93细胞的差异表达基因富集通路相同。结论SGLT1抑制剂MIZA可能通过PI3K-Akt、MAPK等通路抑制多囊肾细胞的增殖和纤维化,延缓多囊肾的生长,是ADPKD的一个潜在治疗靶点。 展开更多
关键词 常染色体显性多囊肾病 钠-葡萄糖共转运体1 细胞增殖 纤维化 磷脂酰肌醇3-激酶 蛋白激酶B 丝裂原活化蛋白激酶 信号通路
下载PDF
GLP-1RA联合SGLT2i治疗超重/肥胖T2DM患者的效果及安全性研究
15
作者 龙杰文 卢燕红 谢明 《系统医学》 2024年第22期93-96,共4页
目的探究胰高血糖素样肽-1受体激动剂(glucagon-like peptide-1 receptor agonist,GLP-1RA)联合钠-葡萄糖协同转运蛋白2抑制剂(sodium-glucose transporter 2 inhibitors,SGLT2i)治疗超重/肥胖2型糖尿病(type2 diabetes mellitus,T2DM)... 目的探究胰高血糖素样肽-1受体激动剂(glucagon-like peptide-1 receptor agonist,GLP-1RA)联合钠-葡萄糖协同转运蛋白2抑制剂(sodium-glucose transporter 2 inhibitors,SGLT2i)治疗超重/肥胖2型糖尿病(type2 diabetes mellitus,T2DM)患者的效果及安全性。方法非随机选取2020年3月—2022年5月肇庆市第二人民医院收治的62例超重/肥胖T2DM患者作为研究对象,按照治疗方法的不同分成两组,各31例。对照组接受SGLT2i治疗,研究组接受GLP-1RA联合SGLT2i治疗,对比两组血糖指标、体重指数、治疗效果、不良反应发生情况。结果研究组的血糖水平和体重指数均低于对照组,差异有统计学意义(P均<0.05)。研究组治疗有效率为96.8%(30/31),优于对照组的77.4%(24/31),差异有统计学意义(χ^(2)=4.897,P<0.05)。研究组的不良反应总发生率与对照组对比,差异无统计学意义(P>0.05)。结论超重/肥胖T2DM患者应用GLP-1RA联合SGLT2i治疗,可以大幅度降低机体的血糖水平与体重指数,且不增加不良反应,治疗效果显著。 展开更多
关键词 胰高血糖素样肽-1受体激动剂 钠-葡萄糖协同转运蛋白2抑制剂 超重 肥胖 2型糖尿病 安全性
下载PDF
多晶材料NaNi_(1/3)Fe_(1/3)Mn_(1/3)O_(2)的合成与性能
16
作者 王洪波 张亚兰 +2 位作者 张佳怡 马大千 张天然 《电池》 CAS 北大核心 2024年第5期612-616,共5页
在未来储能市场和低速车领域,钠离子电池前景广泛,正极材料的选择很关键。采用共沉淀法并结合高温烧结制备层状氧化物NaNi_(1/3)Fe_(1/3)Mn_(1/3)O_(2)(NFM333),借助XRD、SEM和恒流充放电等方法,分析NFM333材料的结构、形貌和电化学性能... 在未来储能市场和低速车领域,钠离子电池前景广泛,正极材料的选择很关键。采用共沉淀法并结合高温烧结制备层状氧化物NaNi_(1/3)Fe_(1/3)Mn_(1/3)O_(2)(NFM333),借助XRD、SEM和恒流充放电等方法,分析NFM333材料的结构、形貌和电化学性能。NFM333材料为典型的O3结构,呈现多晶特征,作为钠离子电池正极具有较高的比容量、良好的倍率性能和稳定的循环性能。材料以0.3C在2.0~4.0 V充放电,-20℃、-30℃和-40℃下的放电比容量分别为20℃下的85.55%、72.88%和45.19%。循环伏安(CV)测试发现,较好的电化学性能归因于较高的离子扩散速率和良好的离子迁移动力学。 展开更多
关键词 钠离子电池 NaNi_(1/3)Fe_(1/3)Mn_(1/3)O_(2)(NFM333) 多晶材料 共沉淀法
下载PDF
SGLT2抑制剂与GLP-1受体激动剂对2型糖尿病患者血糖指标的影响研究
17
作者 韩雪 孙丽 《糖尿病新世界》 2024年第15期70-73,共4页
目的探讨2型糖尿病(type 2 diadetes mellitus,T2DM)患者应用钠-葡萄糖共转运蛋白-2(sodium-glucose transporter 2,SGLT2)抑制剂与胰高血糖素样肽1(glucagon-like peptide-1,GLP1)受体激动剂的效果。方法选取2022年2月—2023年3月四平... 目的探讨2型糖尿病(type 2 diadetes mellitus,T2DM)患者应用钠-葡萄糖共转运蛋白-2(sodium-glucose transporter 2,SGLT2)抑制剂与胰高血糖素样肽1(glucagon-like peptide-1,GLP1)受体激动剂的效果。方法选取2022年2月—2023年3月四平市中心人民医院收治的153例T2DM患者,按治疗方法不同分为对照1组(二甲双胍治疗)、对照2组(二甲双胍+SGLT2抑制剂治疗)与研究组(二甲双胍+SGLT2抑制剂+GLP-1受体激动剂治疗),各51例。比较3组血糖指标、胰岛功能和不良反应发生情况。结果治疗后,3组空腹血糖、餐后2 h血糖、糖化血糖蛋白指标均较治疗前降低,对照2组和研究组均较对照1组低,且研究组低于对照2组,差异有统计学意义(P均<0.05)。治疗后,3组空腹胰岛素水平下降,对照2组和研究组均较对照1组高,且研究组高于对照2组;而胰岛素抵抗指数降低,且对照2组和研究组均较对照1组低,且研究组低于对照2组,差异有统计学意义(P均<0.05)。3组不良反应发生率比较,差异无统计学意义(P>0.05)。结论SGLT2抑制剂与GLP-1受体激动剂在2型糖尿病中的应用效果好,有利于改善患者血糖指标和胰岛素功能,且不会增加不良反应,安全性高。 展开更多
关键词 钠-葡萄糖共转运蛋白-2 胰高血糖素样肽1受体激动剂 2型糖尿病 血糖指标
下载PDF
NASICON型Na_(1+x)Zr_(2)Si_(x)P_(3-x)O_(12)固态电解质及其钠金属电池研究进展
18
作者 许希军 林见烽 +2 位作者 罗雄伟 赵经纬 霍延平 《无机盐工业》 CAS CSCD 北大核心 2024年第11期1-14,38,共15页
锂离子电池由于具有较高的工作电压和能量密度实现了商业化。然而,有限的锂资源限制了其广泛应用。钠离子电池展现出与锂离子电池相似的电化学特性,并且钠盐资源更加丰富,因此受到了广泛关注。目前,钠离子电池使用的是有机电解液,这存... 锂离子电池由于具有较高的工作电压和能量密度实现了商业化。然而,有限的锂资源限制了其广泛应用。钠离子电池展现出与锂离子电池相似的电化学特性,并且钠盐资源更加丰富,因此受到了广泛关注。目前,钠离子电池使用的是有机电解液,这存在一系列安全隐患,如漏液和燃烧等,采用固态电解质可以有效解决这些问题。然而,电解质的离子电导率仍有待提升,且材料制备的一致性及与电极间的界面阻抗问题限制了其广泛应用。针对离子电导率的问题,总结分析了不同价态离子取代的影响。针对存在的界面问题,从正极、负极两侧分析了现有Na_(1+x)Zr_(2)Si_(x)P_(3-x)O_(12)电解质的界面改性方法。最后,对Na_(1+x)Zr_(2)Si_(x)P_(3-x)O_(12)电解质的发展方向进行了展望,有望推动固态钠离子电池的发展。 展开更多
关键词 钠离子电池 固态电解质 Na_(1+x)Zr_(2)Si_(x)P_(3-x)O_(12) 离子电导率 界面修饰
下载PDF
冠心病患者经皮冠状动脉介入术相关造影剂急性肾损害的影响因素分析及KIM-1、NGAL、NHE3的预测价值 被引量:2
19
作者 陈西 羡微微 +3 位作者 盛勇 张国民 孙生健 于翠迪 《中国现代医学杂志》 CAS 2024年第4期51-57,共7页
目的探究冠状动脉粥样硬化性心脏病(以下简称冠心病)患者经皮冠状动脉介入术(PCI)相关造影剂急性肾损害(CIAKI)的影响因素,并分析尿液中肾损伤分子-1(KIM-1)、中性粒细胞明胶酶相关脂质结合蛋白(NGAL)、钠/氢交换蛋白3(NHE3)预测CIAKI... 目的探究冠状动脉粥样硬化性心脏病(以下简称冠心病)患者经皮冠状动脉介入术(PCI)相关造影剂急性肾损害(CIAKI)的影响因素,并分析尿液中肾损伤分子-1(KIM-1)、中性粒细胞明胶酶相关脂质结合蛋白(NGAL)、钠/氢交换蛋白3(NHE3)预测CIAKI发生的价值。方法回顾性分析2021年7月—2022年6月在齐齐哈尔医学院附属第一医院行PCI的142例冠心病患者的病历资料,根据患者术后是否发生CIAKI,分为CIAKI组和非CIAKI组。分析影响PCI术后发生CIAKI的因素,评估PCI前后KIM-1差值、NGAL差值及NHE3差值对PCI术后发生CIAKI的预测价值。结果142例行PCI的冠心病患者中发生CIAKI 25例(17.61%)。CIAKI组糖尿病占比及造影剂使用剂量高于非CIAKI组(P<0.05),术前GFR水平低于非CIAKI组(P<0.05)。CIAKI组手术前后尿KIM-1、NGAL及NHE3的差值均高于非CIAKI组(P<0.05)。多因素逐步Logistic回归分析结果显示:糖尿病[OR=3.350(95%CI:1.145,9.802)]、造影剂使用剂量[OR=3.377(95%CI:1.154,9.880)]、KIM-1差值[OR=4.958(95%CI:1.695,14.506)]、NGAL差值[OR=4.446(95%CI:1.519,13.008)]、NHE3差值[OR=4.446(95%CI:1.519,3.008)]是冠心病患者PCI术后发生CIAKI的危险因素(P<0.05);GFR[OR=0.262(95%CI:0.089,0.765)]是冠心病患者PCI术后发生CIAKI的保护因素(P<0.05)。受试者工作特征曲线分析结果表明,KIM-1差值、NGAL差值、NHE3差值单一及联合预测冠心病患者PCI术后发生CIAKI的敏感性为75.32%(95%CI:0.594,0.831)、68.59%(95%CI:0.537,0.762)、62.77%(95%CI:0.514,0.735)、80.93%(95%CI:0.629,0.924),特异性为74.01%(95%CI:0.583,0.826)、83.16%(95%CI:0.652,0.941)、78.92%(95%CI:0.603,0.875)、81.15%(95%CI:0.638,0.945),曲线下面积为0.743、0.748、0.762和0.837,联合诊断效能最高。结论糖尿病、GFR、造影剂使用剂量和PCI前后KIM-1、NGAL、NHE3的变化影响CIAKI的发生,PCI前后KIM-1差值、NGAL差值及NHE3差值联合预测CIAKI的效能较好。 展开更多
关键词 冠状动脉粥样硬化性心脏病 经皮冠状动脉介入术 造影剂急性肾损害 肾损伤分子-1 中性粒细胞明胶酶相关脂质结合蛋白 钠/氢交换蛋白3
下载PDF
GLP-1受体激动剂与SGLT2抑制剂联合治疗2型糖尿病的临床效果与安全性评估
20
作者 刘燕 《糖尿病新世界》 2024年第17期93-95,99,共4页
目的探讨胰高糖素样肽-1(glucagon-like peptide-1,GLP-1)受体激动剂与钠-葡萄糖协同转运蛋白2(sodium-dependent glucose transporters 2,SGLT2)抑制剂联合治疗2型糖尿病(type 2 diabetes mellitus,T2DM)的效果。方法选取2022年1月—2... 目的探讨胰高糖素样肽-1(glucagon-like peptide-1,GLP-1)受体激动剂与钠-葡萄糖协同转运蛋白2(sodium-dependent glucose transporters 2,SGLT2)抑制剂联合治疗2型糖尿病(type 2 diabetes mellitus,T2DM)的效果。方法选取2022年1月—2024年1月贵州省安顺市人民医院收治的60例T2DM患者为研究对象,按照治疗方法的不同分为两组,各30例。对照组采用二甲双胍、GLP-1受体激动剂治疗,观察组采用GLP-1受体激动剂、SGLT2抑制剂治疗。比较两组血糖指标、血脂指标及不良反应。结果治疗后,观察组空腹血糖、餐后2 h血糖、糖化血红蛋白水平均低于对照组,差异有统计学意义(P均<0.05)。治疗后,观察组总胆固醇、低密度脂蛋白水平均低于对照组,差异有统计学意义(P均<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论GLP-1受体激动剂与SGLT2抑制剂联合治疗T2DM的效果较为理想,可控制患者血糖水平,改善患者血脂指标,且药物安全性较高。 展开更多
关键词 2型糖尿病 胰高糖素样肽-1受体激动剂 钠-葡萄糖协同转运蛋白2抑制剂 血糖
下载PDF
上一页 1 2 37 下一页 到第
使用帮助 返回顶部